Haynes and Boone represented Eos Energy Enterprises, Inc. in the transaction, and Cooley advised Cerberus Capital Management, L.P. Eos Energy Enterprises, Inc. (NASDAQ: EOSE), a leader...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Brightstar Capital Partners on the transaction, and Cooley advised PlayAGS, Inc. Brightstar Capital Partners (“Brightstar”) has announced its $1.1 billion acquisition of...
You must be a Standard 1 Year member to access this content.
Cooley advised INOVIO Pharmaceuticals, while Paul Hastings LLP advised Oppenheimer & Co. and Citizens JMP as joint book running managers in the offering. INOVIO executed an...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised EQT Private Equity Asia on the transaction, and Cooley advised WSO2. EQT Private Equity Asia announced it has entered into an agreement to...
You must be a Standard 1 Year member to access this content.
Cooley advised ChrysCapital on the deal. ChrysCapital, a top India-focused private equity firm, announced the close of its oversubscribed $700 million continuation fund with two of the...
You must be a Standard 1 Year member to access this content.
Cooley, Travers Thorp Alberga and Jun He Law Offices advised ProfoundBio and Wilson Sonsini Goodrich and Rosati advised ProfoundBio on patent matters related to the transaction,...
You must be a Standard 1 Year member to access this content.
Cooley advised Rubicon Technology Partners on the transaction, and Kirkland & Ellis advised Silversmith Capital Partners. Ascend Analytics (“Ascend”), a leading provider of energy transition analytics...
You must be a Standard 1 Year member to access this content.
Cooley advised Akeso, Inc. on the offering. Akeso, Inc. (Hong Kong Exchange code: 9926.HK), a commercial-stage biopharmaceutical company, announced its HK$1.2 billion (appr. USD$153.29 million) follow-on public...
You must be a Standard 1 Year member to access this content.
Haynes and Boone is advising BiomX Inc. on the transaction, Cooley is advising Adaptive Phage Therapeutics and Wilmer Cutler Pickering Hale and Dorr is advising the...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Totango, Inc. in the transaction, and Cooley represented Catalyst Software Corporation. Totango, Inc., a portfolio company of Great Hill Partners, announced its merger...
You must be a Standard 1 Year member to access this content.
